Small choroidal melanoma: outcomes following apical height dose brachytherapy.
CONCLUSION: Small choroidal melanomas treated with iodine-125 episcleral brachytherapy have excellent outcomes. The majority (69%) of patients retained VA of 20/50 or better with very high local control and ocular survival rate (99.3%) with the absence of metastasis (100%).
PMID: 32878827 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Yupari RJ, Bena J, Wilkinson A, Suh J, Singh A Tags: Br J Ophthalmol Source Type: research
More News: Brachytherapy | Eye Cancers | Iodine | Melanoma | Opthalmology | Skin Cancer | Study | UK Health | Uveal Melanoma